Portfolio Management
A recent proliferation in therapeutic technology has placed increased demands on the limited R&D budgets. We believe that the sponsors leveraging the best analytic and predictive platforms will have a clear advantage when it comes to allocation of those resources.
Asset Prioritization
The right investment on
the right internal asset
Our platform enables highly nuanced modeling and predictions for each of the planned an ongoing studies in a portfolio. The user-friendly interface will automatically derive, extract, and compare the key study features (study budget, PTS, commercial forecast, NPV, etc). that the sponsor needs in order to prioritize.
Asset Synergy and Overlap
Identifying and characterizing potential combinations, sequences, and risks of cannibalization
A key element of portfolio architecture is the ability to optimize and mitigate the overlaps of the assets and studies within. Our platform can help identify these overlaps and understand the pros, cons, and even key uncertainties that define them.
Gaps and Opportunities
What are the key strategic areas
we are leaving uncovered,
and how do we address those?
Using foundational disease “maps” to characterize subsets, lines of therapy, and other features, the QuantHealth Platform identifies for the sponsor the contrast between what their portfolio can and will cover, versus where the sponsor wants to be, or perhaps even more importantly, where it should be in order to compete and win.